Ophthalmology · Boston, MA
NPI
1205916442
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
50 Staniford St, Suite 600
Boston, MA, 02114
Phone (617) 367-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$569K
5,770 services
Medicare patients, 2024
1,884
Average age 76
Drug cost, 2024
$666K
4,467 prescriptions
Company payments, 2025
$217
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel J Hu was code 92014 (ophthalmological e&m), 1,319 times for 1,263 patients. In total Daniel J Hu billed 5,770 services in 38 codes, and Medicare paid $569K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,319 | 1,263 | $88.64 | $117K |
| 66984 Cataract Surgery | Office | 762 | 43 | $0.96 | $734 |
| 99213 Office E&M - Established | Office | 666 | 417 | $62.91 | $42K |
| 92136 Ultrasound - Nonspecific | Office | 654 | 495 | $31.08 | $20K |
| 66984 Cataract Surgery | Facility | 548 | 346 | $403.56 | $221K |
| 92012 Ophthalmological E&M | Office | 525 | 458 | $68.85 | $36K |
| 92133 Computerized Ophthalmic Imaging | Office | 228 | 221 | $24.97 | $5,692 |
| 92083 Vision, Hearing, and Speech Services | Office | 225 | 219 | $46.10 | $10K |
| 92134 Computerized Ophthalmic Imaging | Office | 159 | 125 | $30.89 | $4,911 |
| 99204 Office E&M - New | Office | 125 | 125 | $113.42 | $14K |
| 66821 Cataract Surgery | Facility | 115 | 111 | $275.94 | $32K |
| 92004 Ophthalmological E&M | Office | 74 | 74 | $109.88 | $8,131 |
| 92132 Computerized Ophthalmic Imaging | Office | 43 | 42 | $22.56 | $970 |
| 66982 Cataract Surgery | Facility | 32 | 26 | $572.67 | $18K |
| 92025 Test - Miscellaneous | Office | 17 | 16 | $25.45 | $433 |
By year: 2022 $470K for 4,646 services; 2023 $484K for 5,776 services; 2024 $569K for 5,770 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel J Hu prescribed most often to Medicare patients was Prednisolone Acetate, with 1,271 prescriptions and refills. In total Daniel J Hu wrote 4,467 Medicare prescriptions that cost $666K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 1,271 | 1,469 | 696 | $38K |
| Moxifloxacin Moxifloxacin Hcl | 749 | 752 | 472 | $14K |
| Bromfenac Sodium Generic | 346 | 557 | 232 | $65K |
| Latanoprost Generic | 281 | 658 | 83 | $4,210 |
| Brimonidine Tartrate Generic | 190 | 263 | 55 | $8,742 |
| Timolol Maleate Generic | 171 | 366 | 51 | $4,363 |
| Valacyclovir Valacyclovir Hcl | 142 | 280 | 45 | $7,429 |
| Erythromycin Erythromycin Base | 137 | 143 | 47 | $1,941 |
| Restasis Cyclosporine | 124 | 311 | 56 | $186K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 111 | 239 | 37 | $1,895 |
| Ketorolac Tromethamine Generic | 89 | 109 | 63 | $865 |
| Prolensa Bromfenac Sodium | 82 | 118 | 58 | $30K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 78 | 78 | 58 | $773 |
| Fluorometholone Generic | 68 | 123 | 21 | $4,959 |
| Tyrvaya Varenicline Tartrate | 41 | 41 | Under 11 | $27K |
Brand drugs: 1,997 claims; generic drugs: 2,470 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel J Hu $217 ($217 in general payments such as food, travel and fees) from 6 companies. The largest payer was RxSight Inc with $84.14.
| Company | Payments | Amount |
|---|---|---|
| RxSight Inc RXST | 1 | $84.14 |
| Dompe US, Inc. | 1 | $31.45 |
| Alcon Vision LLC ALC | 1 | $25.77 |
| Glaukos Corporation GKOS | 1 | $25.69 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $24.87 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $24.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.